Show items per page
Elements: 113
Page 1 on 3
 TitleAuthors / EditorsDate
add to browser selection
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? Calmy, Alexandra 2018
add to browser selection
High prevalence of physical inactivity among patients from the Swiss HIV Cohort Study Schäfer, Juliane; Young, Jim; Calmy, Alexandra; Nicca, Dunja; ... Bucher, Heiner C 2017
add to browser selection
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP) Ciaffi, Laura; Koulla-Shiro, Sinata; Sawadogo, Adrien Bruno; Ndour, Cheik Tidiane; ... Calmy, Alexandra 2017
add to browser selection
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study Sculier, Delphine; Gayet-Ageron, Angèle; Battegay, Manuel; Cavassini, Matthias; ... Calmy, Alexandra 2017
add to browser selection
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study Wittkop, Linda; Arsandaux, Julie; Trevino, Ana; Schim van der Loeff, Maarten; ... Matheron, Sophie 2017
add to browser selection
Disentangling human tolerance and resistance against HIV. Regoes, Roland R; McLaren, Paul J; Battegay, Manuel; Bernasconi, Enos; ... Fellay, Jacques 2014
add to browser selection
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study Bertisch, Barbara; Franceschi, Silvia; Lise, Mauro; Vernazza, Pietro; ... Clifford, Gary 2013
add to browser selection
Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis Ford, Nathan; Calmy, Alexandra; Andrieux-Meyer, Isabelle; Hargreaves, Sally; ... Shubber, Zara 2013
add to browser selection
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure Marcelin, Anne-Geneviève; Delaugerre, Constance; Beaudoux, Céline; Descamps, Diane; ... Flandre, Philippe 2013
add to browser selection
Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland Crisinel, Pierre-Alex; Posfay Barbe, Clara; Aebi, Christoph; Cheseaux, Jean-Jacques; ... Siegrist, Claire-Anne 2012
add to browser selection
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration Lewden, Charlotte; Bouteloup, Vincent; De Wit, Stéphane; Sabin, Caroline; ... Chêne, Geneviève 2012
add to browser selection
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2012
add to browser selection
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings Calmy, Alexandra; Balestre, Eric; Bonnet, Fabrice; Boulle, Andrew; ... Dabis, François 2012
add to browser selection
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study Staehelin, Cornelia; Keiser, Olivia; Calmy, Alexandra; Weber, Rainer; ... Furrer, Hansjakob 2012
add to browser selection
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection Clifford, G M; Lise, M; Franceschi, S; Egger, M; ... Schöni-Affolter, F 2012
add to browser selection
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study Cain, Lauren E; Logan, Roger; Robins, James M; Sterne, Jonathan A C; ... Wyler, Claire-Anne 2011
add to browser selection
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study Young, J; Scherrer, Anne Paule Marie; Günthard, H F; Opravil, M; ... Bucher, H C 2011
add to browser selection
Management of resistant mucocutaneous herpes simplex infections in AIDS patients: a clinical and virological challenge Barde, C; Piguet, Vincent; Pechere, Marc; Masouyé, Isabelle; ... Toutous Trellu, Laurence Marie 2011
add to browser selection
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures Scherrer, A. U.; von Wyl, Viktor; Fux, C. A.; Opravil, Milos; ... Gunthard, Huldrych 2010
add to browser selection
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals Ray, Maile; Logan, Roger; Sterne, Jonathan A C; Hernández-Díaz, Sonia; ... Hernán, Miguel A 2010
add to browser selection
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children Rudin, Christoph; Wolbers, Marcel; Nadal, David; Rickenbach, Martin; Bucher, Heiner C 2010
add to browser selection
Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries Pujades-Rodriguez, Mar; Balkan, Suna; Arnould, Line; Brinkhof, Martin A. W.; Calmy, Alexandra 2010
add to browser selection
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy Rohrbach, Janine; Robinson, Nicola; Harcourt, Gillian; Hammond, Emma; ... Rauch, Andri 2010
add to browser selection
Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008 Keiser, Olivia; Spoerri, Adrian; Brinkhof, Martin W. G.; Hasse, Barbara; ... Egger, Mathias 2010
add to browser selection
CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2 Asmuth, David M.; Goodrich, James; Cooper, David A.; Haubrich, Richard; ... Valdez, Hernan 2010
add to browser selection
Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir Gutmann, Christine; Cusini, Alexia; Gunthard, Huldrych F.; Fux, Christoph; ... Vernazza, Pietro L. 2010
add to browser selection
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals Elzi, Luigia; Kaufmann, Gilbert; Weber, Rainer; Fux, C. A.; ... Battegay, Manuel 2009
add to browser selection
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland Myers, Catherine; Posfay Barbe, Clara; Aebi, Christoph; Cheseaux, Jean-Jacques; ... Siegrist, Claire-Anne 2009
add to browser selection
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study Bellini, C.; Keiser, Olivia; Chave, J-P; Evison, Jm; ... Cavassini, M. 2009
add to browser selection
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era Boffi El Amari, Emmanuelle; Toutous-Trellu, Laurence; Gayet-Ageron, Angèle; Baumann, Michele; ... Hirschel, Bernard 2008
add to browser selection
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy Polesel, Jerry; Clifford, Gary M.; Rickenbach, Martin; Dal Maso, Luigino; ... Franceschi, Silvia 2008
add to browser selection
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children Rudin, Christoph; Burri, Marcus; Shen, Yang; Rode, Richard; Nadal, David 2008
add to browser selection
HIV transmission under highly active antiretroviral therapy Vernazza, Pietro; Hirschel, Bernard; Bernasconi, Enos; Flepp, Markus 2008
add to browser selection
Antiretroviral treatment during pregnancy Keiser, Olivia; Gayet-Ageron, Angèle; Rudin, Christoph; Brinkhof, M. W.; ... de Tejada, B. M. 2008
add to browser selection
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen Fox, Zoe; Phillips, Andrew; Cohen, Cal; Neuhaus, Jacquie; ... Lundgren, Jens 2008
add to browser selection
Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir Ananworanich, Jintanat; Gayet-Ageron, Angèle; Ruxrungtham, Kiat; Chetchotisakd, Ploenchan; ... Hirschel, Bernard 2008
add to browser selection
HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy Rauch, Andri; Nolan, David; Furrer, Hansjakob; McKinnon, Elizabeth; ... James, Ian 2008
add to browser selection
Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study Wunder, D M.; Fux, C A.; Bersinger, N A.; Mueller, N J.; ... Furrer, H. 2008
add to browser selection
Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting Mangclaviraj, Somsamorn; Kerr, Stephen J.; Chaithongwongwatthana, Surasith; Ananworanich, Jintanat; ... Phanuphak, Praphan 2008
add to browser selection
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy Khanna, Nina; Opravil, Milos; Furrer, Hansjakob; Cavassini, Matthias; ... Kaufmann, Gilbert R. 2008
add to browser selection
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection Fätkenheuer, Gerd; Nelson, Mark; Lazzarin, Adriano; Konourina, Irina; ... van der Ryst, Elna 2008
add to browser selection
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial El-Sadr, W. M.; Grund, B.; Neuhaus, J.; Babiker, A.; ... Neaton, J. D. 2008
add to browser selection
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study Emery, Stéphane; Neuhaus, J. A.; Phillips, A. N.; Babiker, A.; ... Wood, R. 2008
add to browser selection
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study Simcock, Mathew; Blasko, Monika; Karrer, Urs; Bertisch, Barbara; ... Koller, M. T. 2007
add to browser selection
The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial Vernazza, Pietro; Daneel, Synove; Schiffer, Veronique; Decosterd, Laurent; ... Hirschel, Bernard 2007
add to browser selection
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy Wolbers, Marcel; Battegay, Manuel; Hirschel, Bernard; Furrer, Hansjakob; ... Bucher, H. C. 2007
add to browser selection
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. 2007
add to browser selection
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy Wunder, D. M.; Bersinger, N. A.; Fux, C. A.; Mueller, N. J.; ... Furrer, Hansjakob 2007
add to browser selection
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score Mocroft, Amanda; Ledergerber, Bruno; Zilmer, Kai; Kirk, Ole; ... Lundgren, J. D. 2007
add to browser selection
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2007
<< previous | 1 | 2 | 3 |